Avedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.
Read More
Avedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.
Read More
©2021. All Rights Reserved. Medical website design by Glacial Multimedia, Inc.
If you are using a screen reader and are having problems using this website, please call 201-692-9434. Accessibility || Website Disclaimer | Privacy Policy
